Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

FSD Pharma Inc C.HUGE

Alternate Symbol(s):  HUGE

FSD Pharma Inc. is a Canada-based biotechnology company. The Company operates through two segments: Biotechnology and Strategic Investments. Its Biotechnology segment is focused on furthering the research and development of the Company’s two primary drug candidates consisting of Lucid-MS and Lucid-PSYCH, as well as the development of UNBUZZD. The Company’s Strategic Investments segment is focused on generating returns and cashflow through the issuance of loans secured by residential or commercial real estate property. Lucid-PSYCH is a molecular compound identified for the potential treatment of mental health disorders. Lucid-MS is a molecular compound identified for the potential treatment of neurodegenerative disorders. UNBUZZD is a proprietary formulation of natural ingredients, vitamins, and minerals to help with liver and brain function for the purposes of potentially quickly relieving from the effects of alcohol consumption, such as inebriation, and restoring normal lifestyle.


CSE:HUGE - Post by User

Bullboard Posts
Post by M416416on Dec 18, 2018 2:52pm
115 Views
Post# 29130732

ISOL RS WITH HUGE RS

ISOL RS WITH HUGE RS

ISOL THEN and NOW

 

 

 

Isodiol begins trading on consolidated basis

 

2018-07-24 08:36 ET - News Release

 

Mr. Marcos Agramont reports

ISODIOL INTERNATIONAL INC. FINALIZES SHARE CONSOLIDATION

Further to the company's news release dated June 27, 2018, the consolidated common shares of Isodiol International Inc. at a ratio of one postconsolidated common share for every 10 preconsolidated common shares held will commence trading on the Canadian Securities Exchange on July 24, 2018. The new Cusip number will be 46500L 20 0 and the new ISIN number will be CA 46500L 20 0 3.

Following the consolidation, the company's issued and outstanding common shares will be reduced from 395,803,482 to approximately 39,580,349. Any resulting fractional share entitlement remaining after conversion at 0.5 or over will be rounded up to the nearest whole number and below 0.5 will be rounded down to the nearest whole number.

A letter of transmittal will be sent by mail to registered shareholders on July 27, 2018, advising that the consolidation has taken effect. The letter of transmittal will contain instructions on how registered shareholders can exchange their share certificates and/or DRS statements evidencing their preconsolidated common shares for new share certificates and/or new DRS statements representing the number of postconsolidated common shares to which they are entitled. No action is required by non-registered shareholders (shareholders who hold their shares through an intermediary) to effect the consolidation.

About Isodiol Int

 

 

 

 

Bullboard Posts